| Literature DB >> 15020037 |
Phyllis J Goodman1, Catherine M Tangen, John J Crowley, Susan M Carlin, Anne Ryan, Charles A Coltman, Leslie G Ford, Ian M Thompson.
Abstract
The Prostate Cancer Prevention Trial is a randomized double blind chemoprevention trial of 18,882 men. It is designed to test the difference in the histologically proven prostate cancer prevalence between a group of participants given finasteride and another given placebo for 7 years. We present an overview of the study design, details of the administrative structure of the study and a description of the successful implementation of the accrual phase.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15020037 DOI： 10.1016/j.cct.2003.11.007
Source DB: PubMed Journal: Control Clin Trials ISSN： 0197-2456